| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226363.3 |
Tanespimycin |
Lung squamous cell carcinoma |
0.013991951 |
Resistant |
| ENSG00000226363.3 |
Tanespimycin |
Sarcoma |
0.035462661 |
Resistant |
| ENSG00000226363.3 |
Tanespimycin |
Thyroid carcinoma |
0.012705086 |
Sensitive |
